Cyclophosphamide (Hydrated)
CAS Number
6055-19-2Synonym
Cyclophosphamide monohydrate; Endoxan monohydrate; Genoxal; Mitoxan
Occurrence/Use
Medicine (antineoplastic- treatment for malignant lymphoma, multiple myeloma, leukemias), defleecing sheep, insect sterilant
Cancer Potency Information
| Inhalation Unit Risk (μg/cubic meter)-1: | 1.6 E-4 |
|---|---|
| Inhalation Slope Factor (mg/kg-day)-1: | 5.7 E-1 |
| Oral Slope Factor (mg/kg-day)-1: | 5.7 E-1 |
| Comments/References: |
OEHHA 1992. Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens. |
Proposition 65
Chemical Status
| Cancer: | Currently listed |
|---|---|
| Reproductive Toxicity : | Currently listed |
Cancer
Cancer - Listing Mechanism
Labor Code
| Listed as causing : | Listed as causing: Cancer |
|---|---|
| Date of Listing: |
Reproductive Toxicity
Date of Listing
| Listed as causing: | Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity |
|---|---|
| Developmental Toxicity | |
| Date of Listing: | |
| Basis for Listing : | State's Qualified Experts |
| Male Reproductive Toxicity | |
| Date of Listing: | |
| Basis for Listing : | Formally Required |
| Female Reproductive Toxicity | |
| Basis for Listing: | Formally Required |
Safe Harbor Levels
No Significant Risk Level (NSRL)
1 µg/day
| Cancer | |
| Last NSRL/MADL Revision: | 1992 |
|---|
Documents, Presentations, and Publications
| Cancer: |
|
|---|